Showing 961-970 of 1148 results for "".
Bruxism in the Neurology Clinic
https://practicalneurology.com/diseases-diagnoses/movement-disorders/bruxism-in-the-neurology-clinic/30531/Though rarely a primary presentation in the general neurology practice, teeth grinding, gritting, or clinching may present as a trigger for other neurologic complaints.Expert Opinion
https://practicalneurology.com/columns/practice-management/expert-opinion/30799/Central Diabetes Insipidus: A Case StudyAdvancements in MS Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancements-in-ms-therapy/30862/New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.Reversible and Benign Lesions of Splenium of The Corpus Collosum
https://practicalneurology.com/diseases-diagnoses/imaging-testing/reversible-and-benign-lesions-of-splenium-of-the-corpus-collosum/30269/Aggressive diagnostic and therapeutic approaches are often unnecessary.Expert Opinion: Bickerstaff's Brainstem Encephalitis: A Rare Variant Of The Anti-Gq1b Antibody Syndrome
https://practicalneurology.com/columns/practice-management/bickerstaffs-brainstem-encephalitis-a-rare-variant-of-the-anti-gq1b-antibody-syndrome/30708/Vascular Cognitive Impairment, Part 2
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment-part-2/30582/Cognitive impairment after acute stroke is likely under-appreciated despite its impact.Fluid Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging.Monitoring Disease Course and Treatment Response in Various Populations With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monitoring-disease-course-and-treatment-response-in-various-populations-with-multiple-sclerosis/33144/Monitoring for signs of disease activity or progression in multiple sclerosis—a crucial component of disease management—may need refinement for pediatric, pregnant or postpartum, older, and minority or underserved populations.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.